These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 30525219)
1. AGAP2-AS1 serves as an oncogenic lncRNA and prognostic biomarker in glioblastoma multiforme. Tian Y; Zheng Y; Dong X J Cell Biochem; 2019 Jun; 120(6):9056-9062. PubMed ID: 30525219 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1. Luo W; Li X; Song Z; Zhu X; Zhao S Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer. Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway. Zheng Y; Lu S; Xu Y; Zheng J Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575 [TBL] [Abstract][Full Text] [Related]
5. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3. Chen J; Peng X; Dai Y Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485 [TBL] [Abstract][Full Text] [Related]
6. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672 [TBL] [Abstract][Full Text] [Related]
7. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma. Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517 [TBL] [Abstract][Full Text] [Related]
8. Glioma-derived exosome Lncrna Agap2-As1 promotes glioma proliferation and metastasis by mediating Tgf-β1 secretion of myeloid-derived suppressor cells. Tian Y; Gao X; Yang X; Chen S; Ren Y Heliyon; 2024 May; 10(9):e29949. PubMed ID: 38699039 [TBL] [Abstract][Full Text] [Related]
9. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4. Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490 [TBL] [Abstract][Full Text] [Related]
10. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma. Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728 [TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA Ma F; Zhang B; Wang Y; Lou C Molecules; 2024 Jul; 29(15):. PubMed ID: 39124865 [TBL] [Abstract][Full Text] [Related]
12. Expression analysis of vimentin and the related lncRNA network in breast cancer. Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061 [TBL] [Abstract][Full Text] [Related]
13. LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma. Zhou C; Jiang X; Liang A; Zhu R; Yang Y; Zhong L; Wan D Neurosci Lett; 2021 Nov; 764():136245. PubMed ID: 34530115 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA HAS2-AS1 promotes tumor progression in glioblastoma via functioning as a competing endogenous RNA. Zhang L; Wang H; Xu M; Chen F; Li W; Hu H; Yuan Q; Su Y; Liu X; Wuri J; Yan T J Cell Biochem; 2020 Jan; 121(1):661-671. PubMed ID: 31385362 [TBL] [Abstract][Full Text] [Related]
15. AGAP2-AS1: An Indispensable lncRNA in Tumors. Chen J; Wang B Mini Rev Med Chem; 2023; 23(3):336-342. PubMed ID: 35708074 [TBL] [Abstract][Full Text] [Related]
16. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity. Zheng Z; Chen M; Xing P; Yan X; Xie B Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994 [TBL] [Abstract][Full Text] [Related]
17. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88. Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918 [TBL] [Abstract][Full Text] [Related]
18. The lncRNA EGFR-AS1 is linked to migration, invasion and apoptosis in glioma cells by targeting miR-133b/RACK1. Dong ZQ; Guo ZY; Xie J Biomed Pharmacother; 2019 Oct; 118():109292. PubMed ID: 31545240 [TBL] [Abstract][Full Text] [Related]
19. Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p. Gao W; Li H; Liu Y; Zhang Y; Zhao H; Liu F Mol Med Rep; 2020 Aug; 22(2):723-732. PubMed ID: 32626942 [TBL] [Abstract][Full Text] [Related]
20. EIF4A3 stabilizes the expression of lncRNA AGAP2-AS1 to activate cancer-associated fibroblasts via MyD88/NF-κb signaling. Xu Q; Zhao T; Han H; Fan J; Xie W Thorac Cancer; 2023 Feb; 14(5):450-461. PubMed ID: 36541122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]